GPD1L acts as tumor suppressor in cancers32,33; one mechanism is to inhibit the activity of prolyl hydroxylase (PHD), which hydroxylates prolines in HIF-1α and promotes its proteasome degradation21,33. The gene discussed is PDC; the disease is neoplasm.